Triple

T6905244
Position Surface form Disambiguated ID Type / Status
Subject Walter Cannon E159795 entity
Predicate influencedBy P9 FINISHED
Object Claude Bernard E29891 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Claude Bernard | Statement: [Walter Cannon, influencedBy, Claude Bernard]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Claude Bernard
Context triple: [Walter Cannon, influencedBy, Claude Bernard]
  • A. Claude Bernard chosen
    Claude Bernard was a pioneering 19th-century French physiologist regarded as one of the founders of experimental medicine and modern physiology.
  • B. François Magendie
    François Magendie was a pioneering 19th-century French physiologist known for his foundational experiments on the nervous system and for helping establish experimental physiology as a scientific discipline.
  • C. Jean-Antoine Carrel
    Jean-Antoine Carrel was a 19th-century Italian mountain guide and climber renowned for his pioneering ascents in the Alps and Andes.
  • D. Charles Richet
    Charles Richet was a French physiologist and Nobel laureate best known for his pioneering work on anaphylaxis and allergic reactions.
  • E. Émile Roux
    Émile Roux was a French physician, bacteriologist, and pioneer of immunology who played a key role in developing vaccines and antitoxins, notably for diphtheria.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c68839ccb88190b4aa5cc1aca3448f completed March 27, 2026, 1:38 p.m.
NER Named-entity recognition batch_69c6d98b07f0819093595e958fa0317b completed March 27, 2026, 7:24 p.m.
NED1 Entity disambiguation (via context triple) batch_69c769f2269c8190a476287a8ad4bec9 completed March 28, 2026, 5:41 a.m.
Created at: March 27, 2026, 2:25 p.m.